Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Eicosapentaenoic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Breast Neoplasms 3 Weight Loss 2 Polyps 2 Hyperplasia 2 Stomach Neoplasms 1 Psoriasis 1 Osteoarthritis 1 Neoplasms 1 Muscular Atrophy 1 Muscle Weakness 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Chronic-Phase 1 Colitis, Ulcerative 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Cancer Cachexia 1 Cachexia 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Anorexia 1 Adenomatous Polyps 1 Adenomatous Polyposis Coli 1

Interventions

Rituximab 305 Cyclophosphamide 287 Etoposide 125 fludarabine phosphate 124 Peripheral Blood Stem Cell Transplantation 107 fludarabine 104 Filgrastim 103 Melphalan 91 Mycophenolic Acid 87 Whole-Body Irradiation 80 Vincristine 80 Cytarabine 77 Busulfan 77 Doxorubicin 71 Radiotherapy 70 Prednisone 67 Cyclosporine 67 Tacrolimus 64 Bendamustine Hydrochloride 61 Methotrexate 56 Granulocyte Colony-Stimulating Factor 56 Antilymphocyte Serum 50 Carmustine 48 Dexamethasone 44 Gemcitabine 42 Lenalidomide 41 venetoclax 39 Bortezomib 35 obinutuzumab 33 ibritumomab tiuxetan 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡